INCB177054

· Incyte Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for INCB177054, covering 2026-03-25 to 2026-03-25. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate INCB177054 in Participants With Select Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]